Closing Price ($) | Shares Out (MM) | Market Cap ($MM) |
$0.00 | 0 | $0 |
10-Q | 2019-09-30 | Quarter: 2019-09-30 |
10-Q | 2019-06-30 | Quarter: 2019-06-30 |
10-Q | 2019-03-31 | Quarter: 2019-03-31 |
10-K | 2018-12-31 | Annual: 2018-12-31 |
10-Q | 2018-09-30 | Quarter: 2018-09-30 |
10-Q | 2018-06-30 | Quarter: 2018-06-30 |
10-Q | 2018-03-31 | Quarter: 2018-03-31 |
10-K | 2017-12-31 | Annual: 2017-12-31 |
10-Q | 2017-09-30 | Quarter: 2017-09-30 |
10-Q | 2017-06-30 | Quarter: 2017-06-30 |
10-Q | 2017-03-31 | Quarter: 2017-03-31 |
10-K | 2016-12-31 | Annual: 2016-12-31 |
10-Q | 2016-09-30 | Quarter: 2016-09-30 |
10-Q | 2016-06-30 | Quarter: 2016-06-30 |
10-Q | 2016-03-31 | Quarter: 2016-03-31 |
10-K | 2015-12-31 | Annual: 2015-12-31 |
10-Q | 2015-09-30 | Quarter: 2015-09-30 |
10-Q | 2015-06-30 | Quarter: 2015-06-30 |
10-Q | 2015-03-31 | Quarter: 2015-03-31 |
10-K | 2014-12-31 | Annual: 2014-12-31 |
10-Q | 2014-09-30 | Quarter: 2014-09-30 |
10-Q | 2014-06-30 | Quarter: 2014-06-30 |
10-Q | 2014-03-31 | Quarter: 2014-03-31 |
10-K | 2013-12-31 | Annual: 2013-12-31 |
8-K | 2019-11-05 | Enter Agreement, Earnings, Shareholder Vote, Other Events, Exhibits |
8-K | 2019-11-05 | Enter Agreement, Earnings, Shareholder Vote, Other Events, Exhibits |
8-K | 2019-09-27 | Other Events |
8-K | 2019-08-20 | Other Events |
8-K | 2019-08-15 | Other Events, Exhibits |
8-K | 2019-08-15 | Other Events, Exhibits |
8-K | 2019-08-13 | Earnings, Other Events, Exhibits |
8-K | 2019-08-06 | Regulation FD, Other Events, Regulation FD, Exhibits |
8-K | 2019-08-06 | Regulation FD, Other Events, Regulation FD, Exhibits |
8-K | 2019-08-05 | Enter Agreement, Regulation FD, Other Events, Exhibits |
8-K | 2019-08-05 | Enter Agreement, Regulation FD, Other Events, Exhibits |
8-K | 2019-06-06 | Other Events, Exhibits |
8-K | 2019-05-07 | Earnings, Other Events, Exhibits |
8-K | 2019-04-18 | Regulation FD, Exhibits |
8-K | 2019-03-12 | Earnings, Other Events, Exhibits |
8-K | 2019-03-07 | Other Events, Exhibits |
8-K | 2018-08-15 | Other Events, Exhibits |
8-K | 2018-07-31 | Enter Agreement, Leave Agreement, Off-BS Arrangement |
8-K | 2018-04-13 | Regulation FD, Exhibits |
8-K | 2017-12-29 | Enter Agreement, Leave Agreement, Off-BS Arrangement, Exhibits |
Comps ($MM TTM) | Market Cap | Assets | Liabilities | Revenue | Gross Profit | Net Income | EBITDA | EV |
---|---|---|---|---|---|---|---|---|
Apollo Education (APOL) | 1,063 | 1,955 | 886 | 2,000 | 0 | -20 | 98 | 579 |
China Crawfish (CACA) | 0 | 0 | 0 | 0 | -0 | -0 | -0 | |
Mirenco (MREO) | ||||||||
Weyland Tech (WEYL) | 11 | 5 | 29 | -1 | -4 | -4 | -5 | |
Lingo Media (LMDC) | 1 | 1 | 0 | 0 | 0 | 0 | -0 | |
Granite Real Estate (GRP) | ||||||||
Wewin Group (WWIN) | 0 | 0 | 0 | 0 | -0 | -0 | -0 | |
MWF Global (MWF) | 0 | 0 | -0 | -0 | -0 | |||
Frontier Digital Media Group (FDMG) | 0 | 0 | 0 | 0 | -0 | -0 | -0 | |
Brighthouse Life Insurance Co of Ny (BHNY) | 9,066 | 8,030 | 237 | 0 | 0 | 3 | -190 | |
G-Mes Holdings (GMES) | 1 | 1 | 1 | 1 | 0 | 0 | -0 | |
Baynon (BNON) | 0 | 0 | 0 | 0 | -0 | -0 | 0 | |
Immune Therapeutics (IMUN) | 0 | 0 | 13 | 0 | 0 | -5 | -5 | -0 |
Green Planet Bio Engineering (GPLB) | 3 | 0 | 0 | 0 | 0 | -0 | -0 | 3 |
Blue Sphere (BLSP) | 1 | 44 | 87 | 8 | 3 | -14 | -14 | 9 |
Therapeutic Solutions (TSOI) | 0 | 0 | 2 | 0 | 0 | -2 | -1 | 0 |
Stem Holdings (STEMH) | 41 | 6 | 1 | 0 | -8 | -7 | -5 | |
SpringWorks (SWTX) | ||||||||
Clean Coal Technologies (CCTC) | 0 | 17 | 0 | 0 | -6 | -3 | 1 | |
Ryanair Holdings (RYAA) | 13,251 | 8,036 | 0 | 0 | 0 | 0 | -35 |
Balance Sheet ($MM) | 2014-03-31 | 2014-06-30 | 2014-09-30 | 2014-12-31 | 2015-03-31 | 2015-06-30 | 2015-09-30 | 2015-12-31 | 2016-03-31 | 2016-06-30 | 2016-09-30 | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 |
Cash | 5 | 6 | 20 | 29 | 31 | 10 | 50 | 31 | 156 | 47 | 19 | 27 | 28 | 25 | 22 | 27 | 34 | 33 | 78 | 73 | 61 | 55 |
Accounts Receivable | ||||||||||||||||||||||
Inventory | ||||||||||||||||||||||
PP&E | 42 | 86 | 270 | 422 | 674 | 911 | 1,207 | 1,230 | 1,338 | 1,454 | 1,453 | 1,445 | 1,434 | 1,422 | 1,411 | 1,397 | 1,382 | 1,369 | 1,357 | 1,342 | 1,330 | |
Assets | 5 | 49 | 111 | 306 | 465 | 695 | 989 | 1,264 | 1,413 | 1,400 | 1,490 | 1,497 | 1,485 | 1,474 | 1,463 | 1,454 | 1,436 | 1,421 | 1,453 | 1,434 | 1,408 | 1,392 |
Accounts Payable | ||||||||||||||||||||||
Long-Term Debt | ||||||||||||||||||||||
Liabilities | 1 | 31 | 64 | 202 | 280 | 450 | 687 | 882 | 877 | 880 | 986 | 1,007 | 1,010 | 1,013 | 1,018 | 1,028 | 1,025 | 1,027 | 1,087 | 1,088 | 1,083 | 1,086 |
Stockholders' Equity | 4 | 18 | 47 | 103 | 183 | 242 | 296 | 373 | 523 | 502 | 481 | 462 | 450 | 431 | 412 | 390 | 411 | 394 | 366 | 346 | 326 | 305 |
Income Statement ($MM) | 2014-03-31 | 2014-06-30 | 2014-09-30 | 2014-12-31 | 2015-03-31 | 2015-06-30 | 2015-09-30 | 2015-12-31 | 2016-03-31 | 2016-06-30 | 2016-09-30 | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 |
Revenue | ||||||||||||||||||||||
Cost of Revenue | ||||||||||||||||||||||
Gross Profit | ||||||||||||||||||||||
R&D | ||||||||||||||||||||||
SG&A | ||||||||||||||||||||||
Tax | ||||||||||||||||||||||
Net Income | -0 | -2 | -2 | -7 | -7 | -11 | -14 | -18 | -10 | -10 | -10 | -8 | -8 | -7 | -8 | -10 | -8 | -9 | -21 | -11 | -12 | -12 |
Cash Flow ($MM) | 2014-03-31 | 2014-06-30 | 2014-09-30 | 2014-12-31 | 2015-03-31 | 2015-06-30 | 2015-09-30 | 2015-12-31 | 2016-03-31 | 2016-06-30 | 2016-09-30 | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 |
Cash Operating | -2 | -1 | -3 | 2 | 9 | 9 | 10 | 12 | 8 | 10 | 10 | 8 | 7 | 12 | 7 | 8 | 2 | 9 | ||||
Cash Investing | -48 | -188 | -160 | -260 | -229 | -262 | -43 | -121 | -88 | -18 | -10 | -6 | -5 | -6 | -3 | -4 | -5 | -5 | -5 | -7 | ||
Cash Financing | 164 | 233 | 279 | 241 | 159 | 4 | 50 | 14 | 4 | -7 | -7 | 3 | -9 | -8 | 43 | -8 | -8 | -9 |